Building a Renal Denervation Program-Panel Discussion

Video Transcription

Video Summary

The video transcript discusses the lack of evidence in the cardiovascular space with sham control for renal denervation therapy. It highlights the challenge of interpreting the impact of a sham arm and the need to educate colleagues on the benefits of this therapy. The discussion also mentions the importance of considering real-world practice data, which shows greater reductions in blood pressure compared to clinical trials. The use of ambulatory blood pressure monitoring is emphasized for clinical trials, but it's not commonly used in clinical practice. The transcript concludes with a discussion on the need for more data in different clinical groups and the potential for forthcoming approvals based on non-inferiority trials.

Keywords

evidence

renal denervation therapy

blood pressure

clinical trials

ambulatory blood pressure monitoring